Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02989194 · ClinicalTrials.gov registry record · Phase 2

Study of an Investigational Monoclonal Antibody, VIS410, in Subjects With Uncomplicated Influenza A

A Phase 2 study of Influenza, sponsored by Visterra.

Completed
Registry status
Phase 2
Development phase
150
Enrollment target
20
Study locations

NCT02989194 is a Phase 2 study of Influenza that has completed, run by Visterra. The registered enrollment target is 150 participants, below the 36,803-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The trial reports 20 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02989194, a Phase 2 study of Influenza, has completed, sponsored by Visterra.

COMPLETED
Registry status
Phase 2
Development phase
150 participants
Enrollment target
20
Study locations

Study Summary

This is a Phase 2a randomized, double-blind, placebo-controlled study designed to assess the safety and tolerability of an investigational monoclonal antibody, VIS410, in subjects with uncomplicated influenza.

Conditions Studied

Influenza

Interventions

  • DRUG Placebo
  • DRUG VIS410 low dose
  • DRUG VIS410 high dose

Study Locations (20)

Other

  • - Asenovgrad
  • - Lom
  • - Rousse
  • - Sofia
  • - Sofia
  • - Velingrad
  • - Paide
  • - Tallinn
  • - Tallinn

Florida

  • - Coral Gables
  • - Homestead
  • - Miami
  • - Miami
  • - Orlando

Louisiana

  • - Eunice
  • - New Orleans

Texas

  • - Houston
  • - McAllen

Alabama

  • - Huntsville

North Carolina

  • - Shelby

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2017-01-06
Est. Completion 2017-10-27
Phase Phase 2

Sponsor

Visterra

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02989194

The ClinicalTrials.gov registry entry for NCT02989194 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 36,803-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The listed sponsor is Visterra, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Influenza appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT02989194 reports 20 study locations spanning 6 distinct geographic areas - top geographies include Other, Florida, Louisiana.

Frequently Asked Questions

What is clinical trial NCT02989194 about?

NCT02989194 is a clinical study titled "Study of an Investigational Monoclonal Antibody, VIS410, in Subjects With Uncomplicated Influenza A". This is a Phase 2a randomized, double-blind, placebo-controlled study designed to assess the safety and tolerability of an investigational monoclonal antibody, VIS410, in subjects with uncomplicated influenza.

What is the current status of trial NCT02989194?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2017-01-06. Estimated completion is 2017-10-27.

What conditions does trial NCT02989194 study?

This clinical trial studies the following conditions: Influenza.

What interventions are being tested in trial NCT02989194?

The interventions under investigation include: Placebo (DRUG), VIS410 low dose (DRUG), VIS410 high dose (DRUG).

Who is sponsoring clinical trial NCT02989194?

This trial is sponsored by Visterra, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02989194 being conducted?

This trial has 20 study locations across Alabama, Florida, Louisiana, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Influenza

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Influenza

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.